Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2357987 | 0.84 | KCNN4 (0.30) | KCNN4 | |
| Hydrochloric Acid SCHEMBL2245514 | 0.83 | MEN1 (0.31) | — | |
| Hydrochloric Acid SCHEMBL2245745 | 0.80 | ALDH1A1 (0.37) | ESR1ESR2 | |
| Hydrochloric Acid SCHEMBL2240349 | 0.80 | KIF11 (0.32) | — | |
| Hydrochloric Acid SCHEMBL6813336 | 0.79 | KCNN4 (0.34) | KCNN4ESR1ESR2 | |
| Hydrochloric Acid SCHEMBL29205569 | 0.79 | KCNN4 (0.34) | KCNN4ESR1ESR2 | |
| Hydrochloric Acid SCHEMBL29205572 | 0.76 | KCNN4 (0.38) | KCNN4ESR1ESR2 | |
| Hydrochloric Acid SCHEMBL6813337 | 0.76 | KCNN4 (0.34) | KCNN4ESR1ESR2 | |
| Hydrochloric Acid SCHEMBL2248628 | 0.76 | CA1 (0.31) | — | |
| Hydrochloric Acid SCHEMBL2246275 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110207977-A1 | METHOD FOR PRODUCING A-OLEFIN OLIGOMER, A-OLEFIN OLIGOMER, AND LUBRICATING OIL COMPOSITION | IDEMITSU KOSAN CO., LTD. (JP) | 2011-08-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110207977-A1 | METHOD FOR PRODUCING A-OLEFIN OLIGOMER, A-OLEFIN OLIGOMER, AND LUBRICATING OIL COMPOSITION | MOGAT2, OSBP, OXER1 | KCNN4 3863/4885ESR1 2277/4885ESR2 2678/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.